Sign in
CompletedNo phase

Randomized Controlled Trial of CES for Fibromyalgia

Key facts

Who runs it
VA Office of Research and Development
Where
Decatur, United StatesSee the site
Trial code
Status
Completed
People taking part
50 people enrolled
Started
2 Mar 2020
Ended
30 Sept 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Alpha-stim
Record updated
22 May 2026

Who can take part

Age
20 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Subjects must be male and female Veterans age 20-60 with a diagnosis of fibromyalgia as diagnosed by a clinician, by chart review, and by the most recent American College of Rheumatology 2010 criteria for the diagnosis of fibromyalgia
  • Subjects must self-report consistent, daily pain (greater than 5 on the VAS) >90 days
  • Subjects must have intact skin free of infection at the site of electrode placement
  • Subjects must be willing to participate and understand the consent
  • Subjects must be right-handed in order to provide consistency in brain structure and function

Who cannot take part

  • Subjects must not introduce new medications or treatments for fibromyalgia symptoms during the course of the study to prevent confounding results
  • Subjects must not have a history of seizures or neurologic condition that may alter the structure of the brain
  • Subjects must not have a history of drug abuse or severe, uncontrolled psychiatric illness such as schizophrenia or major depressive disorder with suicidal ideation
  • Subjects must not have psoriasis vulgaris or other skin conditions that may increase the risk of infection at the implantation site
  • Subjects must not have severe anxiety, claustrophobia, or other conditions that may prevent their ability to lie at rest in an MRI scanner. This will be determined after discussion with the patient regarding their own perceived ability to lie at rest in an MRI scanner without the use of additional sedating medications
  • Subjects must not be currently pregnant, since effects of fMRI and electrical current on the developing fetus are not well-known
  • Subjects must not have an implanted electrical device such as a vagal stimulator, pacemaker, or spinal pain pump, which are not compatible with MRI

Where in United States

  • Atlanta VA Medical and Rehab Center, Decatur, GADecatur, United States

About the trial

What the trial wants to find out

Given recent increasing opioid-related deaths and evidence showing against the use of opioids for non-malignant chronic pain, there is growing need for non-narcotic pain management. Fibromyalgia is a difficult to treat chronic pain condition that is often treated with opioids despite existing evidence. The prevalence of fibromyalgia is increased among Veterans returning from the gulf war and is already a significant burden in senior Veterans who may have suffered with chronic pain for decades already. Many treatment options for fibromyalgia carry intolerable side effects. CES (Cranial Electrical Stimulation) is a FDA-approved, non-pharmacologic therapy that is currently utilized within the military and VA system, but sufficient evidence regarding its outcomes and neural mechanisms have not been adequately investigated. An understanding of its neural underpinnings and analgesic effects could lead to 1) improvements in pain management and quality of life, 2) cost-savings and 3) development of new techniques to address pain.

The 2 groups in the trial

  • True CESTreatment being tested

    Veterans with fibromyalgia who meet study criteria and are randomized to the experimental group will receive standard therapy in addition to cranial electrical stimulation (CES), which involves transfer of current from the alpha-stim device using earclip electrodes. The intention of this FDA-approved device is to relieve pain, though data on its effectiveness is still limited. The treatments can be self administered by the participants. The rs-fcMRI evaluation of neural changes and assessment of clinical pain, function, and quality of life will be performed at the beginning and end of the study.

    Treatment: Alpha-stim

  • Sham CESSham treatment, for comparison

    Veterans with fibromyalgia who meet study criteria and are randomized to the sham comparator group will receive standard therapy in addition to a CES device that does not deliver active electrical stimulation. The intention of this FDA-approved device is to relieve pain, though data on its effectiveness is still limited. The rs-fcMRI evaluation of neural changes and assessment of clinical pain, function, and quality of life will be performed at the beginning and end of the study.

    Treatment: Alpha-stim

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized Double-Blind Placebo-Controlled Trial: fMRI Assessment of Cranial Electrical Stimulation for Fibromyalgia in Veterans
Record updated
22 May 2026